(Q44665397)

5 December 2017

title

In vitro efficacy of l-asparaginase in childhood acute myeloid leukaemia (English)

1 reference

5 December 2017

1 reference

Shuichi Okada

1

1 reference

5 December 2017

Teruaki Hongo

2

1 reference

5 December 2017

Sayuri Yamada

3

1 reference

5 December 2017

Chieko Watanabe

4

1 reference

5 December 2017

Yuji Fujii

5

1 reference

5 December 2017

Takehiko Ohzeki

6

1 reference

5 December 2017

Yasuo Horikoshi

7

1 reference

5 December 2017

Tsuyoshi Ito

8

1 reference

5 December 2017

Makoto Yazaki

9

1 reference

5 December 2017

Yoshihiro Komada

10

1 reference

5 December 2017

Akio Tawa

11

1 reference

5 December 2017

language of work or name

English

0 references

publication date

1 December 2003

1 reference

British Journal of Haematology

5 December 2017

published in

1 reference

5 December 2017

volume

123

1 reference

5 December 2017

issue

5

1 reference

5 December 2017

page(s)

802-809

1 reference

Acute myeloid leukaemia M0: haematological, immunophenotypic and cytogenetic characteristics and their prognostic significance: an analysis in 241 patients

5 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04703.X

Characterization of apoptotic phenomena induced by treatment with L-asparaginase in NIH3T3 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04703.X

The clinical and cellular pharmacology of vincristine, corticosteroids, L-asparaginase, anthracyclines and cyclophosphamide in relation to childhood acute lymphoblastic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04703.X

Glutamine deprivation-mediated cell shrinkage induces ligand-independent CD95 receptor signaling and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04703.X

In vitro resistance to cytosine arabinoside, not to daunorubicin, is associated with the risk of relapse in de novo acute myeloid leukaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04703.X

Use of ?-asparaginase in childhood ALL

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04703.X

A gene expression database for the molecular pharmacology of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04703.X

Sensitivity to L-asparaginase is not associated with expression levels of asparagine synthetase in t(12;21)+ pediatric ALL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04703.X

The World Health Organization (WHO) classification of the myeloid neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04703.X

Cellular drug resistance in childhood acute myeloid leukemia is related to chromosomal abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04703.X

Dose reduction of asparaginase under pharmacokinetic and pharmacodynamic control during induction therapy in children with acute lymphoblastic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04703.X

Prognostic significance of early response to a single dose of asparaginase in childhood acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04703.X

Biology and outcome of childhood acute megakaryoblastic leukemia: a single institution's experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04703.X

Induction therapy with idarubicin alone significantly influences event-free survival duration in patients with newly diagnosed hypergranular acute promyelocytic leukemia: final results of the GIMEMA randomized study LAP 0389 with 7 years of minimal

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04703.X

Asparagine synthetase activity in paediatric acute leukaemias: AML-M5 subtype shows lowest activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04703.X

Relation between age, immunophenotype and in vitro drug resistance in 395 children with acute lymphoblastic leukemia--implications for treatment of infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04703.X

Clinical relevance of in vitro chemoresistance in childhood acute myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04703.X

10.1046/J.1365-2141.2003.04703.X

21 January 2018

Identifiers

DOI

1 reference

5 December 2017

1 reference